ENTRY       D11650                      Drug
NAME        Volanesorsen sodium (USAN);
            Waylivra (TN)
FORMULA     C230H320N63O125P19S19. 19Na
EXACT_MASS  7596.8384
MOL_WEIGHT  7601.891
REMARK      ATC code: C10AX18
            Chemical structure group: DG03070
EFFICACY    Antihyperlipidemic, Apolipoprotein C3 inhibitor
  TYPE      Antisense oligonucleotide
COMMENT     Treatment of familial chylomicronemia syndrome
TARGET      APOC3 [HSA:345] [KO:K08759]
  PATHWAY   hsa03320(345)  PPAR signaling pathway
            hsa04979(345)  Cholesterol metabolism
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C10 LIPID MODIFYING AGENTS
               C10A LIPID MODIFYING AGENTS, PLAIN
                C10AX Other lipid modifying agents
                 C10AX18 Volanesorsen
                  D11650  Volanesorsen sodium (USAN)
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Digestive system
                APOC3
                 D11650  Volanesorsen sodium (USAN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11650
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11650
DBLINKS     CAS: 1573402-50-2
            PubChem: 405226517
///
